Prestige Consumer Healthcare Inc. balance sheet
At the end of fiscal 2026, Prestige Consumer Healthcare Inc. had total assets of $3.49bn, total liabilities of $1.61bn and shareholders' equity of $1.89bn. It held $63.9m in cash against $1.00bn of debt.
Balance sheet
| Fiscal year | 2010Mar 2010 | 2011Mar 2011 | 2012Mar 2012 | 2013Mar 2013 | 2014Mar 2014 | 2015Mar 2015 | 2016Mar 2016 | 2017Mar 2017 | 2018Mar 2018 | 2019Mar 2019 | 2020Mar 2020 | 2021Mar 2021 | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 41 | 13 | 19 | 16 | 28 | 21 | 27 | 42 | 33 | 28 | 95 | 32 | 27 | 58 | 46 | 98 | 64 | 89 |
| Receivables | — | 44 | 73 | 73 | 65 | 88 | 95 | 137 | 146 | 149 | 151 | 115 | 139 | 167 | 177 | 194 | 192 | 187 |
| Inventory | — | 40 | 51 | 60 | 66 | 74 | 91 | 116 | 117 | 120 | 116 | 115 | 120 | 162 | 139 | 148 | 159 | 190 |
| Total current assets | — | 108 | 147 | 164 | 177 | 202 | 249 | 334 | 303 | 301 | 366 | 270 | 293 | 392 | 375 | 448 | 431 | 497 |
| Goodwill | 111 | 155 | 174 | 168 | 191 | 291 | 360 | 615 | 620 | 579 | 575 | 578 | 579 | 528 | 528 | 527 | 581 | 651 |
| Total assets | — | 1,057 | 1,758 | 1,740 | 1,796 | 2,642 | 2,949 | 3,911 | 3,761 | 3,441 | 3,514 | 3,429 | 3,671 | 3,354 | 3,318 | 3,402 | 3,494 | 4,569 |
| Accounts payable | — | 22 | 27 | 51 | 48 | 46 | 38 | 70 | 61 | 57 | 62 | 46 | 56 | 63 | 39 | 19 | 23 | 37 |
| Total current liabilities | — | 54 | 64 | 97 | 84 | 99 | 107 | 162 | 123 | 127 | 150 | 122 | 143 | 161 | 117 | 107 | 121 | 154 |
| Short-term debt | — | — | — | — | 0 | 0 | — | — | — | — | — | 0 | — | — | — | — | 0 | 10 |
| Long-term debt | — | 487 | 1,124 | 971 | 934 | 1,561 | 1,625 | 2,194 | 1,993 | 1,799 | 1,730 | 1,480 | 1,477 | 1,346 | 1,135 | 992 | 994 | 2,007 |
| Total debt | 0 | 487 | 1,135 | 978 | 938 | 1,594 | 1,653 | 2,222 | 2,013 | 1,813 | 1,745 | 1,495 | 1,495 | 1,360 | 1,135 | 1,000 | 1,000 | 2,045 |
| Total liabilities | — | 695 | 1,356 | 1,262 | 1,232 | 2,014 | 2,204 | 3,089 | 2,582 | 2,345 | 2,343 | 2,071 | 2,093 | 1,907 | 1,663 | 1,567 | 1,607 | 2,652 |
| Shareholders' equity | 329 | 362 | 403 | 478 | 563 | 628 | 744 | 823 | 1,179 | 1,096 | 1,171 | 1,358 | 1,578 | 1,447 | 1,655 | 1,835 | 1,888 | 1,917 |
| Quarter | 2025 Q2Sept 2024 | 2025 Q3Dec 2024 | 2025 Q4Mar 2025 | 2026 Q1Jun 2025 | 2026 Q2Sept 2025 | 2026 Q3Dec 2025 | 2026 Q4Mar 2026 | 2027 Q1Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 164 | 167 | 194 | 168 | 199 | 190 | 192 | 187 |
| Inventory | 156 | 152 | 148 | 153 | 159 | 164 | 159 | 190 |
| Total current assets | 381 | 377 | 448 | 481 | 497 | 433 | 431 | 497 |
| Goodwill | 529 | 527 | 527 | 528 | 528 | 581 | 581 | 651 |
| Total assets | 3,317 | 3,329 | 3,402 | 3,432 | 3,442 | 3,495 | 3,494 | 4,569 |
| Accounts payable | 31 | 20 | 19 | 22 | 42 | 43 | 23 | 37 |
| Total current liabilities | 107 | 103 | 107 | 110 | 135 | 140 | 121 | 154 |
| Short-term debt | — | — | — | — | — | — | 0 | 10 |
| Long-term debt | 1,060 | 1,000 | 992 | 993 | 993 | 1,034 | 994 | 2,007 |
| Total debt | 1,060 | 1,000 | 992 | 993 | 993 | 1,034 | 994 | 2,018 |
| Total liabilities | 1,585 | 1,541 | 1,567 | 1,576 | 1,617 | 1,665 | 1,607 | 2,652 |
| Shareholders' equity | 1,732 | 1,788 | 1,835 | 1,855 | 1,825 | 1,829 | 1,888 | 1,917 |
Compare with peers
- Trulieve Cannabis Corp. balance sheet
- ANI Pharmaceuticals Inc balance sheet
- Harmony Biosciences Holdings, Inc. balance sheet
- Indivior Pharmaceuticals, Inc. balance sheet
- Axsome Therapeutics, Inc. balance sheet
Head to head: PBH vs TRLVANIP vs PBHHRMY vs PBH
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies